| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,021 |
8,582 |
$453K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,199 |
4,848 |
$339K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
542 |
533 |
$35K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
854 |
829 |
$31K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
325 |
320 |
$12K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
194 |
192 |
$10K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
91 |
90 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
165 |
164 |
$3K |
| 0240U |
|
18 |
18 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
55 |
54 |
$1K |
| 90686 |
|
142 |
140 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
13 |
$660.87 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
69 |
31 |
$404.40 |
| 81003 |
|
369 |
351 |
$106.22 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
136 |
130 |
$16.86 |